Our read is that individuals should get a colonoscopy, with experts advocating for aggressive and frequent screening due to its high efficacy in preventing colon cancer.
✓WELLSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
Consensus
100%
broad agreement
Evidence quality
75/100
developing
Risk
High
specialist only
Cost / month
$
estimated
Effort
Low
time & habit
Abstract
Our read is that colonoscopies are a well-supported method for preventing colon cancer, which experts state is 100% preventable because every colon cancer originates from a polyp detectable during the procedure.
Experts suggest starting colonoscopies around age 40, or earlier for those with specific risk factors, and recommend a frequency more often than every five to ten years, with some advocating for every one to three years.
While generally considered safe, individuals should weigh their personal risk-reward tradeoff and cost-benefit analysis when determining screening frequency.
Method
Fecal occult blood testing and fecal DNA tests are sensible precursors to colonoscopy for colorectal cancer surveillance. More frequent colonoscopy surveillance may be warranted if polyps are present or if the bowel preparation is incomplete.
Evidence detail
01Peter Attia and Andrew Huberman (4x) claim that colon cancer is 100% preventable because every colon cancer originates from a polyp that can be detected during a colonoscopy.
02Rhonda Patrick (1x) states that colonoscopy possesses 100% sensitivity and very high specificity for detecting colon cancer.
03Bryan Johnson (1x) notes that colonoscopy screening is associated with a 52% reduction in colorectal cancer incidence and a 62% reduction in mortality.
04Peter Attia (2x) claims that having a colonoscopy every one to two years makes the likelihood of developing colon cancer extremely remote.
Conflict Watch
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Peter Attia and Rhonda Patrick (3x) recommend the age for a first colonoscopy for individuals with no history of colon cancer is 40.
06Peter Attia (1x) recommends colonoscopies and upper endoscopies with a frequency of every one to three years.
07Peter Attia (6x) plans to get colonoscopies every three years until his life expectancy is too short for them to be relevant.
08Rhonda Patrick (1x) states that colonoscopy is a very safe procedure in good hands, with no reported incidents in a study of over 20,000 people.
09Peter Attia (1x) claims the benefits of early and frequent colon cancer screening are asymmetric, particularly for individuals who have had colon cancer before age 50.
Caveats
Peter Attia and Rhonda Patrick (3x) note that risks of colonoscopy include electrolyte abnormalities from bowel preps and sedation. Peter Attia (1x) points out that cancer can develop as soon as six to eight months after a normal colonoscopy. Rhonda Patrick (1x) mentions that standard colonoscopy recommendations have shifted to starting at age 45, with some debate on 5-10 year intervals. Peter Attia (1x) also states that colonoscopy screening every 10 years shows a statistically significant benefit in reducing colon cancer and mortality, but with minimal clinical significance.
What would change this verdict
New evidence suggesting that the risks of complications from colonoscopies outweigh the benefits, or that alternative screening methods offer comparable or superior efficacy with fewer risks, would change the verdict. Additionally, if experts were to widely agree on less frequent screening intervals without a significant increase in cancer incidence, this could also alter the recommendation.
121Advocates
51Skeptics
35Neutral
⌕
Sort
Advocates
121
Evidence ScoreEvidence Score
SM
Sarah Mwangi· Founder
Founder ·60 claims
97
RH
Renu Halberg· RN
RN ·47 claims
97
CN
Caleb Nakashima· MD/PhD
MD/PhD ·70 claims
96
ES
Esther Stoltz· Author
Author ·58 claims
96
HH
Hana Hoffman· Coach
Coach ·52 claims
96
TN
Tessa Nakamura· MD
MD ·91 claims
96
ZN
Zaynab Nakamura· PhD
PhD ·48 claims
95
Skeptics
51
Evidence ScoreEvidence Score
EE
Esi Eze· RN
RN ·68 claims
83
RO
Renu Okafor· MD/PhD
MD/PhD ·90 claims
82
HR
Hannah Roth· MD
MD ·79 claims
81
RS
Renu Saito· PhD
PhD ·85 claims
81
MW
Marc Whitlock· PhD
PhD ·44 claims
81
AL
Adrián Larsson· Coach
Coach ·64 claims
81
LY
Lior Yamamoto· Founder
Founder ·86 claims
80
Neutral
35
Evidence ScoreEvidence Score
RR
Rohan Rodriguez· DO
DO ·83 claims
88
MN
Maya Nascimento· PhD
PhD ·74 claims
88
HO
Henrik Okafor· MD/PhD
MD/PhD ·13 claims
88
IW
Iris Whitlock· Coach
Coach ·92 claims
87
EH
Eitan Halberg· MS
MS ·22 claims
87
LL
Lior Lindqvist· PharmD
PharmD ·80 claims
86
PP
Priya Patel· PhD
PhD ·42 claims
86
Verdict
Sort
From advocates
2026-02-08
The effect size is large enough to matter clinically, not just statistically.
RCZW+1Ruth Cheng, Bryan Johnson +2
RCZW+14 creators
✓WELLSUPPORTED
2026-01-09
Mechanistic and trial evidence converge on a real, replicable effect.
RMZKFW+1Ruth Marchetti, Zaynab Kjær +2
RMZKFW+14 creators
✓WELLSUPPORTED
2026-03-19
The effect size is large enough to matter clinically, not just statistically.
TBEA+1Tessa Bautista, Esther Achebe +2
TBEA+14 creators
✓WELLSUPPORTED
2026-03-03
The intervention improves the primary outcome at standard doses in healthy adults.
SBZKRTSarah Bhatia, Zaynab Kjær +1
SBZKRT3 creators
✓WELLSUPPORTED
2026-03-24
Benefits hold across the populations where it's been tested.
JPTNTTJoaquín Park, Tessa Nakamura +1
JPTNTT3 creators
✓WELLSUPPORTED
From skeptics
2026-02-09
Animal-model results don't translate to the human protocol being recommended.
STEWEH+1Sarah Tanaka, Eitan Wexler +2
STEWEH+14 creators
◐PARTIALLYSUPPORTED
2026-05-13
The headline effect shrinks once you account for trial quality.
⚠ High-risk claim
AMHRCO+1Anders Marchetti, Hannah Roth +2
AMHRCO+14 creators
◐PARTIALLYSUPPORTED
2026-05-23
Animal-model results don't translate to the human protocol being recommended.
ALNMAdrián Larsson, Ngozi Marchetti
ALNM2 creators
◐PARTIALLYSUPPORTED
2026-02-13
Animal-model results don't translate to the human protocol being recommended.
LYRNLM+1Lior Yamamoto, Ruth Nascimento +2
LYRNLM+14 creators
?LIMITEDRESEARCH
2026-03-14
Most of the support comes from short or small studies.